Skip to main content
Clinical Trials/NCT04106648
NCT04106648
Unknown
Not Applicable

Effect of Significant Ischemic Mitral Regurgitation on the Outcome of ST Segment Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Intervention

Assiut University0 sites134 target enrollmentNovember 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ischemic Mitral Regurgitation
Sponsor
Assiut University
Enrollment
134
Primary Endpoint
effect of ischemic mitral regurgitation on the outcome of STEMI patients treated with successful primary PCI
Last Updated
6 years ago

Overview

Brief Summary

The goal of the study is to correlate the effect of ischemic mitral regurgitation on the outcome of STEMI patients treated with successful primary PCI using clinical data and echocardiography on presentation and during short term follow up after 3 months

Detailed Description

* IMR is defined as mitral regurgitation (MR) caused by chronic changes of LV structure and function due to ischemic heart disease. It is not a valve disease but represents the valvular consequences of increased tethering forces and reduced closing forces. It is reported in approximately one-fifth of patients following acute myocardial infarction (MI) and one-half of those with congestive heart failure. IMR is a frequent complication of coronary artery disease and it worsens the prognosis. * It is important to distinguish between primary MR due to organic disease of one or more components of the mitral valve apparatus and secondary MR which is not a valve disease, but represents LV disease. Secondary MR is defined as functional MR, due to LV remodeling by cardiomyopathy or coronary artery disease. In the latter clinical setting, secondary functional MR is called IMR. There are some limitations in this definition of functional IMR. Recent studies have revealed evidence of structural changes in the mitral leaflets in response to tethering on them by LV pathological remodeling. The leaflet adaptation includes enlargement and increased stiffness. * Aim of the work : To correlate the effect of ischemic mitral regurgitation on the outcome of STEMI patients treated with successful primary PCI using clinical data and echocardiography on presentation and during short term follow up after 3 months

Registry
clinicaltrials.gov
Start Date
November 1, 2020
End Date
September 20, 2023
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Fady Usama Amin Kostandy

Principal investigator

Assiut University

Eligibility Criteria

Inclusion Criteria

  • Subjects with first presentation
  • Subjects with Acute STEMI
  • Subjects undergoing Primary PCI with Successful reperfusion
  • Subjects with significant IMR Grade (III/IV) to (IV/IV)
  • Subjects with acute STEMI with no or non-significant MR undergoing Primary PCI undergoing primary PCI with successful reperfusion (as control)

Exclusion Criteria

  • Rheumatic mitral regurge
  • Valvular mitral regurge
  • IMR Grade (II/IV)
  • Cardiomyopathies
  • Associated other valvular heart diseases

Outcomes

Primary Outcomes

effect of ischemic mitral regurgitation on the outcome of STEMI patients treated with successful primary PCI

Time Frame: 3 months

clinical data and echocardiography

Similar Trials